Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Protara Therapeutics (TARA)

Protara Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TARA
DateTimeSourceHeadlineSymbolCompany
13/01/202521:34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TARAProtara Therapeutics Inc
13/01/202513:00GlobeNewswire Inc.Protara Highlights Recent Updates and Anticipated 2025 MilestonesNASDAQ:TARAProtara Therapeutics Inc
08/01/202513:00GlobeNewswire Inc.Protara Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:TARAProtara Therapeutics Inc
07/01/202521:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
07/01/202521:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
07/01/202521:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
17/12/202421:02Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:TARAProtara Therapeutics Inc
11/12/202421:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TARAProtara Therapeutics Inc
11/12/202421:05GlobeNewswire Inc.Protara Announces Closing of $100 Million Public OfferingNASDAQ:TARAProtara Therapeutics Inc
10/12/202404:35GlobeNewswire Inc.Protara Announces Pricing of $100 Million Public OfferingNASDAQ:TARAProtara Therapeutics Inc
09/12/202421:17Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TARAProtara Therapeutics Inc
09/12/202421:01GlobeNewswire Inc.Protara Announces Proposed Public OfferingNASDAQ:TARAProtara Therapeutics Inc
05/12/202413:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TARAProtara Therapeutics Inc
05/12/202412:00GlobeNewswire Inc.Protara Announces Positive Results from the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBCNASDAQ:TARAProtara Therapeutics Inc
18/11/202411:01Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:TARAProtara Therapeutics Inc
15/11/202422:52GlobeNewswire Inc.Protara Therapeutics to Present New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC at the 25th Annual Meeting of the Society of Urologic OncologyNASDAQ:TARAProtara Therapeutics Inc
14/11/202418:00Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:TARAProtara Therapeutics Inc
14/11/202417:19Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:TARAProtara Therapeutics Inc
12/11/202413:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TARAProtara Therapeutics Inc
12/11/202413:00GlobeNewswire Inc.Protara Therapeutics Announces Third Quarter 2024 Financial Results and Provides a Business UpdateNASDAQ:TARAProtara Therapeutics Inc
06/11/202413:00GlobeNewswire Inc.Protara Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation ConferenceNASDAQ:TARAProtara Therapeutics Inc
21/10/202412:00GlobeNewswire Inc.Protara Therapeutics Granted FDA Fast Track Designation for Intravenous Choline Chloride for Patients Receiving Parenteral SupportNASDAQ:TARAProtara Therapeutics Inc
13/09/202400:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
10/09/202423:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
09/09/202412:05GlobeNewswire Inc.Protara Therapeutics Announces Completion of First Cohort in Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic MalformationsNASDAQ:TARAProtara Therapeutics Inc
09/09/202412:00GlobeNewswire Inc.Protara Therapeutics Announces Results from THRIVE-1, a Prospective Observational Study Evaluating the Prevalence of Choline Deficiency and Liver Injury in Patients Dependent on Parenteral SupportNASDAQ:TARAProtara Therapeutics Inc
03/09/202412:00GlobeNewswire Inc.Protara Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:TARAProtara Therapeutics Inc
30/08/202420:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TARAProtara Therapeutics Inc
06/08/202420:16Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TARAProtara Therapeutics Inc
06/08/202412:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TARAProtara Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TARA